• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Ranbaxy Laboratories > September 21, 2005

      Ranbaxy may launch anti-malaria drug in 2009

      Posted AtManorma Online

      Pharma giant Ranbaxy Laboratries Ltd said it was likely to launch its anti-malaria drug by 2009 for which the clinical trials were currently going on.

      "We are doing Phase-II clinical trials for a new chemical entity for malaria and if everything goes well we expect the product to hit the market by 2008-09," Malvinder Mohan Singh Ranbaxy President (Pharmaceuticals) said on the sidelines of the CII technology summit.

      The company was conducting clinical trials in three countries at present for the chemical 'synthetic artemesinin'. The drug is likely to be in tablet form. The company added that it would begin its Canadian operations for sales and marketing as part of its strategy to expand in the overseas markets.

      Singh said "we well look at marketing generic products portfolio and drugs which are about to go off-patent." The Canadian operation is a completely sales and marketing oriented and it is part of the company's strategy to expand overseas with Canada being the eight largest pharma market in the world.

      September 21, 2005


      Share this Article!

    Back to top^